A defined chromosome 6q fragment (at D6S310) harbors a putative tumor suppressor gene for breast cancer
- PMID: 8761288
A defined chromosome 6q fragment (at D6S310) harbors a putative tumor suppressor gene for breast cancer
Abstract
Recent evidence obtained by cytogenetic and molecular studies indicates that in breast cancer chromosome 6q is often affected by genetic changes suggesting the existence of putative tumor suppressor genes (TSGs). However the function of gene(s) on this chromosome in breast cancer suppression is not understood. To substantiate further the presence of breast cancer related TSGs at 6q and to define their location, we first performed microcell-mediated transfer of chromosome 6 to CAL51 breast cancer cells for studying possible suppression of malignant phenotype and secondly, we analysed DNAs from 46 primary breast cancers for loss of constitutive heterozygosity (LOH) using 24 poly-morphic microsatellite markers. The chromosome transfer resulted in loss of tumorigenicity and reversion of other neoplastic properties of the microcell hybrids. Polymorphism analysis of single hybrids revealed that they harbored only a small donor chromosome fragment defined by the marker D6S310 (6q23.3-q25) and flanked by D6S292 and D6S311. The LOH data suggest that four tumor suppressor gene loci mapped to the central and distal portion of 6q may be independently deleted in breast cancer. One of these regions corresponds to the region identified by chromosome transfer.
Similar articles
-
Loss of heterozygosity on the long arm of chromosome 6 in breast cancer: possibly four regions of deletion.Clin Cancer Res. 1996 Sep;2(9):1601-6. Clin Cancer Res. 1996. PMID: 9816339
-
Evidence for two tumor suppressor loci associated with proximal chromosome 9p to q and distal chromosome 9q in bladder cancer and the initial screening for GAS1 and PTC mutations.Cancer Res. 1996 Nov 1;56(21):5039-43. Cancer Res. 1996. PMID: 8895761
-
Detailed deletion mapping with a refined physical map of 7q31 localizes a putative tumor suppressor gene for breast cancer in the region of MET.Oncogene. 1996 Nov 7;13(9):2001-8. Oncogene. 1996. PMID: 8934547
-
[Molecular analysis of breast cancers: recent developments].Bull Cancer. 1992;79(12):1115-33. Bull Cancer. 1992. PMID: 1304832 Review. French.
-
The evidence for human tumor suppressor genes.Princess Takamatsu Symp. 1989;20:3-13. Princess Takamatsu Symp. 1989. PMID: 2577336 Review.
Cited by
-
Parkin gene alterations in ovarian carcinoma from northern Indian population.Pathol Oncol Res. 2011 Sep;17(3):579-86. doi: 10.1007/s12253-010-9351-x. Epub 2011 Jan 10. Pathol Oncol Res. 2011. PMID: 21221875
-
A deletion mutation of the protein tyrosine phosphatase kappa (Ptprk) gene is responsible for T-helper immunodeficiency (thid) in the LEC rat.Mamm Genome. 2007 Nov;18(11):779-86. doi: 10.1007/s00335-007-9062-0. Epub 2007 Oct 2. Mamm Genome. 2007. PMID: 17909891
-
Deletion of 11q23 and cyclin D1 overexpression are frequent aberrations in parathyroid adenomas.Am J Pathol. 2001 Apr;158(4):1355-62. doi: 10.1016/S0002-9440(10)64086-2. Am J Pathol. 2001. PMID: 11290553 Free PMC article.
-
Heat shock protein 90 inhibition depletes LATS1 and LATS2, two regulators of the mammalian hippo tumor suppressor pathway.Cancer Res. 2010 Nov 1;70(21):8642-50. doi: 10.1158/0008-5472.CAN-10-1345. Epub 2010 Sep 14. Cancer Res. 2010. PMID: 20841485 Free PMC article.
-
Microenvironmental control of malignancy exerted by RNASET2, a widely conserved extracellular RNase.Proc Natl Acad Sci U S A. 2011 Jan 18;108(3):1104-9. doi: 10.1073/pnas.1013746108. Epub 2010 Dec 28. Proc Natl Acad Sci U S A. 2011. PMID: 21189302 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Medical